Botanical species · safety record

Solidago virgaurea

The EFSA Compendium of Botanicals holds 4 constituent measurements for Solidago virgaurea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Solidago virgaurea L.

4Constituent measurements
0Safety records
3Cited sources
182Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 182 licensed products naming Solidago virgaurea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Aerial parts
  • Dessus fleurissant
  • Flower
  • Flower buds
  • Flower heads
  • Flower tops
  • Flowering aerial part(s)
  • Flowering aerial parts extract

What the records describe

Constituents measured

  • Myrcene2
  • Pentacyclic triterpene saponins2

Plant parts

  • Aerial part of plants4

Preparations

  • Essential oil2
  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
MyrceneAerial part of plantsEssential oil≤ 17.9 PercentGC-MSResolve DOI
MyrceneAerial part of plantsEssential oil≥ 7.8 PercentGC-MSResolve DOI
Pentacyclic triterpene saponinsAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Pentacyclic triterpene saponinsAerial part of plantsSolvent extractionUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kalemba, D. Constituents of the essential oil of Solidago virgaurea L.. Flavour and fragrance journal, 1998, vol. 13, no. 6, p. 373-376. DOI
  2. Laurencon, Lise., Sarrazin, Elise., Chevalier, Marlene., Precheur, Isabelle., Herbette, Gaetan., Fernandez, Xavier. Triterpenoid saponins from the aerial parts of Solidago virgaurea alpestris with inhibiting activity of Candida albicans yeast-hyphal conversion. PHYTOCHEMISTRY, 2013, vol. 86, p. 103-111. DOI
  3. Plohmann, B., Bader, G., Hiller, K., Franz, G. Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie, 1997, vol. 52, no. 12, p. 953-957.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue